We saw some big moves in the biotech/healthcare space today. One of the biggest movers was Arrowhead Pharmaceuticals (ARWR). The stock moved up over 40% during the peak of the session, reaching a high of $22.39 before gradually pulling back to around $19 per share. The stock was up due to positive results on a study of it’s ARO-HBV treatment for HBV patients. Here’s a recap of what happened.
Scott Bauer joins Business First AM to share why he thinks volatility is not going anywhere and why complacency right now could be a costly mistake.
Read Article
Stocks posted a second straight week of gain and the S&P 500 closed above 7,700 for the first time ever earlier this week. The Nasdaq gained over 5% thanks to a bounce-back in chip stocks as the iShares Semiconductor ETF (SOXX) rallied more than 7% this week. The Dow, also had a nice run as all three indexes […]
Read Article
Jeff Bezos just sold 15 million shares of Amazon (AMZN) and the headlines are everywhere. Scott Bauer joined Business First AM to cut through the noise and give his honest take on whether this move should change anything for investors.
Read Article
Scott Bauer joined the IBKR Podcast this week to break down what moved markets last week and what investors need to watch heading into the next stretch of earnings season. From lagging inflation data to big tech CapEx concerns, Scott did not hold back.
Read Article
The Dow rose more than 1% to a record closing high on Thursday ahead of the long holiday weekend as a softer-than-expected U.S. jobs report eased worries about interest rate hikes, while another sharp drop in chipmaker stocks weighed on the Nasdaq. The second half of 2026 kicked off this week much the same as […]
Read Article
A renewed sell-off in technology stocks grabbed headlines this week. The Nasdaq index fell 4.5%, closing lower 5 days in a row, led by a large 5.5% decline in the so-called Magnificent 7 mega cap names. Meanwhile, the post IPO exuberance around SpaceX appears to be fading, with shares now down 25% from their peak. […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.